PEG3 and prostate cancer: It is believed that deregulation of WNT/ β catenin pathway contributes to prostate cancer progression [41–46], and according to [47], inhibition of the transcription factor “PEG3” can lead to enhanced β catenin expression and proliferation in human glioma stem cells.